Biochemical modifications of tau proteins—together with highly toxic Amyloid βeta (Aβ)-1-42 aggregated—have been designated to be among the earliest neurobiological changes and histopathological features of AD. The gene discussed is MAPT; the disease is Alzheimer disease.